BCL2 and acute kidney injury: This evidence directly confirms that USP7-mediated deubiquitination of Bcl-2 is a key mechanism for inhibiting apoptosis in cisplatin-induced AKI, providing a clear target for anti-apoptotic therapy in AKI.